In-hospital Outcome for Diabetic Patients with Acute Myocardial Infarction in the Thrombolytic Era

By Kjærgaard Søren Christensen   Hansen Hans-Henrik Tilsted   Fog Lars   Bülow Inge   Christensen Per Dahl  

Scandinavian Cardiovascular Journal, Vol. 33, Iss. 3, 1999-08 ,pp. : 166-170

Informa Healthcare

Access to resources Recommend Favorite

Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis

By Goudevenos John   Ntalas Ioannis   Xanthopoulou Ioanna   Kalantzi Kallirroi   Pipilis Athanasios   Alexopoulos Dimitrios  

Journal of Thrombosis and Thrombolysis, Vol. 37, Iss. 3, 2014-04 ,pp. : 356-357

Springer Publishing Company

Access to resources Recommend Favorite

Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction

By Karthikeyan Ganesan   Baalasubramanian Sivasankar   Seth Sandeep   Das Nibhriti  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 2, 2007-04 ,pp. : 115-120

Springer Publishing Company

Access to resources Recommend Favorite

Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy

By Ohlin A.-K.   Morser J.   Ohlin H.  

Thrombosis Research, Vol. 82, Iss. 4, 1996-05 ,pp. : 313-322

Elsevier

Access to resources Recommend Favorite

Improvement in Long-term Prognosis of Elderly Patients with Acute Myocardial Infarction After the Introduction of Intravenous Thrombolytic Therapy

By Madsen Johnny Koerstz   Pedersen Flemming   Nielsen Henrik   Jensen Gunnar Vagn   Hansen Jørgen Fischer  

Scandinavian Cardiovascular Journal, Vol. 32, Iss. 6, 1998-11 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite